SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-16-084575
Filing Date
2016-11-02
Accepted
2016-11-02 17:00:23
Documents
1
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 5238
  Complete submission text file 0001140361-16-084575.txt   6969
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Issuer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 614 DAVIS STREET EVANSTON IL 60201
Business Address 614 DAVIS STREET EVANSTON IL 60201 312-589-6400
Pentwater Capital Management LP (Reporting) CIK: 0001425851 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-35953 | Film No.: 161968811